Logo
Euro Gen Epithalon, 10mg

Euro Gen Epithalon, 10mg

Euro-Gen

Research chemical / peptide reagent
  • Supplied and labelled exclusively as a research Use Only peptide reagent, not as a medicinal product, medical device, cosmetic or food.
  • Not authorised or licensed by the MHRA, EMA, FDA or other regulatory authorities for any therapeutic indication.
  • Use governed by general chemical and biological safety regulations and institutional policies applicable to laboratory reagents in the relevant jurisdiction.
  • Researchers and institutions are responsible for ensuring that all experimental uses comply with local laws, ethics approvals and any applicable professional or anti Doping codes.
Synthetic pineal tetrapeptide (Epithalon/Epitalon) for in vitro research

Description

Euro-Gen Epithalon, 10mg is a synthetic research peptide supplied as a lyophilised powder in a sealed vial, intended strictly for in vitro testing and laboratory research. Epithalon (also known as Epitalon or Epithalone) is a tetrapeptide originally derived from the active fraction of the pineal gland extract epithalamin, with the amino acid sequence Ala-Glu-Asp-Gly and molecular formula C14H22N4O9. It has attracted significant interest in geroscience and regenerative biology for its reported ability in experimental systems to modulate telomerase activity, support telomere maintenance, influence oxidative stress responses and affect neuroendocrine and immune functions. The Euro-Gen product is marketed as high-purity research-grade Epithalon for laboratory use only; it is not a licensed medicine, food or cosmetic and is not for human or veterinary administration.

Bnefits

  • Provides a defined 10 mg quantity of Epithalon tetrapeptide per vial for reproducible in vitro and preclinical research.
  • Epithalon (Ala-Glu-Asp-Gly) is a well-characterised pineal tetrapeptide with extensive preclinical literature on telomere biology, oxidative stress, neuroendocrine regulation and immune modulation.
  • Supplied as a lyophilised, research-grade peptide with high claimed purity (typically >99% by HPLC) suitable for analytical, biochemical and cell-based assays.
  • Lyophilised presentation in a sealed vial supports peptide stability during shipping and storage prior to controlled laboratory reconstitution.
  • Useful as a tool compound in mechanistic studies on cellular senescence, telomerase/telomere dynamics, antioxidant responses, and age-related functional decline.
  • Clearly designated as for research use only, helping laboratories maintain a strict separation between experimental reagents and regulated medicinal products.

Indications

  • No approved therapeutic indications; Euro-Gen Epithalon, 10mg is not licensed as a medicine or medical device.
  • Intended exclusively for in vitro and preclinical laboratory research involving Epithalon/Epitalon and related pineal peptides.
  • Suitable for use as a reference peptide in studies of telomerase regulation, telomere maintenance, oxidative stress, mitochondrial function, neuroprotection, endocrine and immune modulation.
  • May be employed under appropriate institutional and ethical approvals in ex vivo and animal models, strictly as a research reagent.
  • Not for human or veterinary injection, ingestion, inhalation, topical application, or any other route of bodily administration.

Composition

  • Active research ingredient: Epithalon (also known as Epitalon, Epithalone, Epithalamin-derived tetrapeptide).
  • Amino-acid sequence (one-letter code): Ala-Glu-Asp-Gly (AEDG).
  • Empirical molecular formula: C14H22N4O9.
  • Approximate molecular weight: 390.35 g/mol.
  • CAS Registry Number: 307297-39-8.
  • Supplied as lyophilised (freeze-dried) peptide powder; any trace excipients used during lyophilisation are not typically specified and may vary by batch.
  • No solvent, buffer or diluent (e.g. bacteriostatic water) is included in the vial; these must be provided separately by the laboratory.

Formulation

  • Lyophilised synthetic Epithalon peptide powder in a sterile, sealed glass vial containing a nominal 10 mg of peptide.
  • Research-grade purity (commonly marketed as >99% by HPLC) suitable for in vitro and preclinical applications.
  • Designed to be reconstituted with an appropriate sterile, laboratory-grade diluent (e.g. bacteriostatic water, sterile saline or assay buffer) by trained personnel, in line with institutional SOPs.
  • Formulated and labelled solely as a research reagent; not formulated as a pharmaceutical dosage form for clinical use.

Packaging

  • Single 10 mg Epithalon lyophilised peptide vial with rubber stopper and crimped cap, labelled with product name, Euro-Gen branding and research-only designation.
  • Vial supplied within secondary packaging (e.g. cardboard carton or protective mailer) from distributors such as Express Peptides or Derma Filler Ltd to minimise damage during transport.
  • Accompanying online product information provides summary of Epithalon research areas, molecular characteristics and research-use-only disclaimers, rather than a patient information leaflet.

Usage

  • For in vitro testing and laboratory research use only; handle exclusively by suitably qualified and authorised laboratory personnel.
  • Any form of bodily administration to humans or animals (injection, ingestion, inhalation, topical application, etc.) is strictly prohibited and outside the intended purpose of the product.
  • Before first use, visually inspect the vial to ensure integrity of the container and lyophilised cake; do not use if the vial is cracked, the seal is compromised or the contents appear abnormal.
  • Reconstitute the lyophilised peptide with an appropriate sterile, laboratory-grade diluent under aseptic conditions according to institutional SOPs and the specific experimental protocol (desired concentration, buffer composition, pH).
  • Label reconstituted solutions with peptide name, concentration, diluent, date of reconstitution and responsible operator; keep accurate batch and usage records for traceability.
  • Store any reconstituted peptide according to internal guidelines (e.g. aliquoting and refrigerating or freezing) and minimise repeated freeze–thaw cycles to reduce degradation.
  • Dispose of unused peptide, reconstituted solutions, vials, syringes, needles and other contaminated consumables as chemical/biological laboratory waste, following institutional and regulatory requirements.
  • Do not treat marketing or online descriptions as medical guidance; Epithalon remains an investigational research peptide and is not approved for therapy or self-experimentation.

Contraindications

  • Use in humans or animals (by any route of administration) is contraindicated and explicitly outside the stated research-only purpose.
  • Should not be used as a substitute for any licensed medicinal product in the management of aging, cancer, neurodegenerative disease or other medical conditions.
  • Not suitable for laboratories lacking appropriate facilities, safety equipment, training and waste-disposal procedures for handling synthetic peptides.
  • Personnel with known hypersensitivity to peptides or specific excipients should avoid direct contact and follow occupational health recommendations.
  • Not to be used in doping, physique enhancement, or any context aimed at circumventing anti-doping rules or medical regulations.

Adverse Effects

  • No formal adverse-effect profile exists for this commercial preparation in humans or animals, as it is not intended for administration.
  • Accidental laboratory exposure (e.g. skin or eye contact, inhalation of dust/aerosol, inadvertent ingestion) may cause non-specific irritation or sensitisation; affected individuals should follow standard laboratory first-aid procedures and seek medical advice if symptoms persist.
  • Unauthorised self-administration or clinical use of research-grade Epithalon may pose unknown and potentially serious risks, including issues related to sterility, impurities, dosing errors, endocrine disruption and long-term safety; such practices are strongly discouraged and outside the intended use.
  • Laboratory staff should consult institutional risk assessments for peptides, use appropriate personal protective equipment (gloves, lab coat, eye protection) and follow good laboratory practice to minimise exposure.

Storage Conditions

  • Store unopened vials in a cool, dry place protected from direct light and moisture; many laboratories keep lyophilised peptides refrigerated (2–8 °C) or frozen (≤ −20 °C) according to internal SOPs.
  • Avoid prolonged exposure to elevated temperatures and repeated temperature cycling; do not use if there are signs of degradation or container damage.
  • After reconstitution, store solutions according to institutional guidelines (e.g. aliquots refrigerated for short-term use or frozen for longer-term storage) and avoid repeated freeze–thaw cycles.
  • Keep vials and reconstituted solutions out of reach of unauthorised personnel and clearly segregated from licensed medicinal products, foods and cosmetics.
  • Comply with any expiry or best-before dates provided by the supplier and dispose of expired or compromised material as laboratory waste in line with local regulations.

Duration

Not applicable. Euro-Gen Epithalon, 10mg is a research reagent with no authorised clinical use, dosing schedule or treatment duration; any therapeutic or performance-enhancement use would be outside its intended scope and contrary to supplier guidance.

Onset

Not applicable to clinical outcomes. In experimental models, any observed effects of Epithalon depend on system type, concentration, exposure protocol and endpoint measured, and cannot be extrapolated to human therapeutic onset or efficacy.

Browse more Research chemical / peptide reagent

Top Treatments

Top Cities in the UK